Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conventional vs high-dose oseltamivir in immunocompromised transplant recipients with influenza
2006-002468-24Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oseltamivir in influenza (2 arms), sponsored by Roche. Primary endpoint: Time to resolution of influenza symptoms. Started Aug 2007; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002468-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002468-24.